1. Loubatières, A.: Etude physiologique et pharmaco-dynamique de certains dérivés sulfamides hypoglycémiants. Arch. Int. Physiol. 54, 174?177 (1946)
2. Pozza, G., Galansino, G., Foà, P.P.: Insulin secretion following carbutamide injections in normal dogs. Proc. Soc. exp. Biol. 93, 539?542 (1956)
3. Creutzfeldt, W., Soling, H.D.: Orale Diabetestherapie und ihre experimentellen Grundlagen. Erg. inn. Med. Kinderheilk. 15, 1?213 (1960)
4. Sussman, K.E., Stjernholm, M., Vaughan, G.D.: Tolbutamide and its effect upon insulin secretion in the isolated perfused rat pancreas. In: Tolbutamide... after ten years, p. 22?33 (ed. by Butterfield, W.J.H, and Van Westering, W.) Amsterdam: Excerpta Med. Found. I.C.S. 149, 1967
5. Loubatières, A., Mariani, M.M., Ribes, G., De Malbose, H., Alric, R., Chapal, J.: Pharmacological study of a new particularly active hypoglycemic sulfonamide. Glibenclamide (HB 419). HB 419 ? new oral anti-diabetic drug, Pub. Symp. 1969, 18?24, 1969